Search clinical trials for: HDAc
Total 181 results
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)TerminatedSoft Tissue Sarcoma | Renal Cell Carcinoma | Metastatic DiseaseUnited States
-
University of ArkansasUniversity of IowaNot yet recruitingPlasma Cell Disorder
-
Hospices Civils de LyonCompletedAcute Myeloid LeukemiaFrance
-
Alison WalkerCompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8... and other conditionsUnited States
-
Karus Therapeutics LimitedUniversity College, LondonWithdrawnBiliary Tract CancerUnited Kingdom
-
Karus Therapeutics LimitedCompletedSolid Tumor, AdultUnited States
-
National Taiwan University HospitalNot yet recruitingIrritable Bowel Syndrome | Metabolic Syndrome | Microbial Colonization
-
Centre Hospitalier Universitaire de NīmesTerminatedStress Disorders, Post-TraumaticFrance
-
AbbVieRecruitingFacial Volume DeficitGermany, Spain
-
Cardiff UniversityCancer Research UKUnknownMyelodysplastic Syndrome | Acute Myeloid LeukaemiaDenmark, United Kingdom
-
University of California, DavisCompleted
-
CopharosUnknownBreast CancerUnited States
-
Directed Systems LimitedUniversity Hospital Birmingham NHS Foundation Trust; Innovate UKCompletedIntraoperative HypotensionUnited Kingdom
-
CopharosUnknownCarcinoma, Non-Small-Cell Lung | Lung Neoplasms | Brain Neoplasms | Metastases, NeoplasmUnited States
-
IVI MadridCompleted
-
NCIC Clinical Trials GroupS*BIOCompleted
-
Chong Kun Dang PharmaceuticalUnknownHuntington DiseaseKorea, Republic of
-
The Netherlands Cancer InstituteUnknownMelanoma | Skin NeoplasmsNetherlands
-
AbbVieRecruiting
-
CelgeneActive, not recruitingLeukemia, Myeloid | Isocitrate DehydrogenaseUnited States, Canada, China, Czechia, France, Germany, Italy, United Kingdom, Australia, Austria, Brazil, Denmark, Korea, Republic of, Russian Federation, Spain, Taiwan, Turkey, Belgium
-
Laboratorios Leti, S.L.Completed
-
AstraZenecaCompletedAcute Myeloid LeukemiaUnited States, Italy, United Kingdom, Romania, Japan, Australia, Germany, Spain, France
-
The Netherlands Cancer InstituteActive, not recruitingBreast CancerNetherlands, France
-
National Institute of Neurological Disorders and...CompletedMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingUnited States
-
AtheroNova Inc.Unknown
-
Yale UniversityMerck Sharp & Dohme LLCCompletedNon-Small Cell Lung Cancer (NSCLC)United States
-
Waisenmedizin e. V. Promoting Access to Essential...University of Freiburg; Waisenmedzin eV PACEM non-profit German NGO; German Medical... and other collaboratorsCompletedWound HealingAfghanistan
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis PharmaceuticalsTerminatedNon-Hodgkin's LymphomaUnited States
-
Icahn School of Medicine at Mount SinaiUnknownMultiple Myeloma | Hodgkin's Disease | Chronic Lymphocytic Lymphoma | Relapsed Non-Hodgkin's LymphomaUnited States
-
Yale UniversityMerck Sharp & Dohme LLCCompletedAdvanced Breast CancerUnited States
-
University Health Network, TorontoNovartis PharmaceuticalsTerminated
-
Copenhagen University Hospital at HerlevUnknownPolycythemia Vera | Essential ThrombocythemiaSweden, United Kingdom, Denmark, Netherlands
-
Rockefeller UniversityAarhus University Hospital; University Hospital of CologneCompletedHuman Immunodeficiency Virus (HIV)Germany, Denmark, United States
-
Fudan UniversityRecruitingPeripheral T-cell LymphomaChina
-
Syndax PharmaceuticalsRecruitingAcute Myeloid LeukemiasUnited States
-
Ada Health GmbHMuhimbili University of Health and Allied SciencesActive, not recruitingNeurological Conditions | Mental Health Conditions | Abdominal Pain/Gastrointestinal Issues | Lower Respiratory System Conditions | Upper Respiratory System Conditions | Ophthalmology Conditions | Orthopedic Conditions | Cardiovascular System Conditions | Genitourinary System Conditions | ENT Conditions | Dermatology Conditions and other conditionsTanzania
-
University of Turin, ItalyCompleted
-
Institute of Hematology & Blood Diseases HospitalUnknown
-
Universidad Autónoma de BucaramangaInstituto Colombiano para el Desarrollo de la Ciencia y la Tecnología (COLCIENCIAS) and other collaboratorsUnknown
-
Centre Hospitalier Universitaire de Saint EtienneMinistry of Health, FranceRecruiting
-
Pascoe Pharmazeutische Praeparate GmbHCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); Parke-DavisCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis; Genentech, Inc.CompletedHead and Neck Cancer | Lung CancerUnited States
-
National Cancer Institute (NCI)CompletedRefractory Lymphoma | Refractory Malignant Solid Neoplasm | Recurrent Lymphoma | Recurrent Malignant Solid Neoplasm | Recurrent Primary Central Nervous System Neoplasm | Refractory Primary Central Nervous System Neoplasm | Brain Stem Neoplasm | Pineal Region Neoplasm | Recurrent Visual Pathway Glioma | Refractory Visual Pathway GliomaUnited States
-
NCIC Clinical Trials GroupS*BIOCompletedUnspecified Adult Solid Tumor, Protocol SpecificCanada
-
National Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
Cooperative Study Group A for HematologyUnknownAcute Myeloid LeukemiaKorea, Republic of
-
National Cancer Institute (NCI)WithdrawnAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory B-Cell Non-Hodgkin Lymphoma | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Pancreatic Carcinoma | Refractory T-Cell Non-Hodgkin Lymphoma | Stage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC... and other conditions
-
PfizerCompletedAcute Myeloid LeukemiaJapan
-
Chroma TherapeuticsCompletedSafety Study of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid TumoursSolid TumorNetherlands, United Kingdom